Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing

British Journal of Anaesthesia

Volumn 101, Issue 3, 2008, Pages 344-349

  Eikermann, M ^a,b,c   Zaremba, S ^a   Malhotra, A ^a   Jordan, A S ^a   Rosow, C ^c   Chamberlin, N L ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Airway, muscles; Airway, obstruction; Airway, patency; Airway, pharynx; Airway, reflexes; Airway, tongue; Neuromuscular block, antagonism: neuromuscular block, neurotransmission effects; Neuromuscular block, pharmacology; Neuromuscular block, recovery

Indexed keywords

FLURANE; GLYCOPYRRONIUM BROMIDE; ISOFLURANE; NEOSTIGMINE; PLACEBO; ROCURONIUM; SUGAMMADEX; UNCLASSIFIED DRUG; ANDROSTANE DERIVATIVE; CHOLINESTERASE INHIBITOR; GAMMA CYCLODEXTRIN DERIVATIVE; INHALATION ANESTHETIC AGENT; NEUROMUSCULAR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTERY CATHETERIZATION; ARTICLE; BREATHING DISORDER; BREATHING MUSCLE; CONTROLLED STUDY; DRUG SAFETY; FEMORAL ARTERY; FEMORAL VEIN; MALE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RAT; TIDAL VOLUME; TRACHEOTOMY; UPPER RESPIRATORY TRACT; VEIN CATHETERIZATION; ANESTHETIC RECOVERY; ANIMAL; BREATHING; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; ELECTROMYOGRAPHY; NEUROMUSCULAR BLOCKING; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INHALATION; ANIMALS; CHOLINESTERASE INHIBITORS; ELECTROMYOGRAPHY; GAMMA-CYCLODEXTRINS; ISOFLURANE; MALE; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION; RESPIRATORY MUSCLES;

EID: 50849154436     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen176     Document Type: Article

References (30)

1. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92: 977-984
2. Eikermann M, Vogt FM, Herbstreit F, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med 2007; 175: 9-15
3. Berg H. Is residual neuromuscular block following pancuronium a risk factor for postoperative pulmonary complications? Acta Anaesthesiol Scand Suppl 1997; 110: 156-158
4. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84: 301-303
5. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology 2003; 98: 1037-1039
6. Arbous MS, Meursing AE, van Kleef JW, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005; 102: 257-68; quiz 491-492
7. Caldwell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg 1995; 80: 1168-1174
8. Churchill-Davidson HC, Christie TH. The diagnosis of neuromuscular block in man. Br J Anaesth 1959; 31: 290-301
9. Eikermann M, Fassbender P, Malhotra A, et al. Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. Anesthesiology 2007; 107: 621-629
10. Yost CS, Maestrone E. Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor. Anesth Analg 1994; 78: 520-526
11. Payne JP, Hughes R, Al Azawi S. Neuromuscular blockade by neostigmine in anaesthetized man. Br J Anaesth 1980; 52: 69-76
12. Legendre P, Ali DW, Drapeau P. Recovery from open channel block by acetylcholine during neuromuscular transmission in zebrafish. J Neurosci 2000; 20: 140-148
13. Cammu G, De Witte J, De Veylder J, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg 2006; 102: 426-429
14. Foster JG, Kish SK, Keenan CH. National practice with assessment and monitoring of neuromuscular blockade. Crit Care Nurs Q 2002; 25: 27-40
15. de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. Br J Anaesth 2006; 96: 473-479
16. de Boer HD, van Egmond J, van de Pol F, Bom A, Driessen JJ, Booij LH. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation. Br J Anaesth 2006; 97: 681-686
17. Hunter JM, Flockton EA. The doughnut and the hole: a new pharmacological concept for anaesthetists. Br J Anaesth 2006; 97: 123-126
18. Chamberlin NL, Eikermann M, Fassbender P, White DP, Malhotra A. Genioglossus premotoneurons and the negative pressure reflex in rats. J Physiol 2007; 579: 515-526
19. Zaimis EJ. Motor end-plate differences as a determining factor in the mode of action of neuromuscular blocking substances. J Physiol 1953; 122: 238-251
20. de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007; 107: 239-244
21. Isono S, Kochi T, Ide T, Sugimori K, Mizuguchi T, Nishino T. Differential effects of vecuronium on diaphragm and geniohyoid muscle in anaesthetized dogs. Br J Anaesth 1992; 68: 239-243
22. D'Honneur G, Gall O, Gerard A, Rimaniol JM, Lambert Y, Duvaldestin P. Priming doses of atracurium and vecuronium depress swallowing in humans. Anesthesiology 1992; 77: 1070-1073
23. Saboisky JP, Gorman RB, De Troyer A, Gandevia SC, Butler JE. Differential activation among five human inspiratory motoneuron pools during tidal breathing. J Appl Physiol 2007; 102: 772-780
24. Gal TJ, Goldberg SK. Relationship between respiratory muscle strength and vital capacity during partial curarization in awake subjects. Anesthesiology 1981; 54: 141-147
25. Tramer MR, Fuchs-Buder T. Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review. Br J Anaesth 1999; 82: 379-386
26. Kopman AF, Kopman DJ, Ng J, Zank LM. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function. J Clin Anesth 2005; 17: 30-35
27. Kopman AF. Tactile evaluation of train-of-four count as an indicator of reliability of antagonism of vecuronium- or atracuriuminduced neuromuscular blockade. Anesthesiology 1991; 75: 588-593
28. Kopman AF. Sugammadex: a revolutionary approach to neuromuscular antagonism. Anesthesiology 2006; 104: 631-633
29. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007; 104: 575-581
30. Sparr HJ, Vermeyen KM, Beaufort AM, et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007; 106: 935-943